Analysis of cell height in the tall cell subtype of papillary thyroid carcinoma. Is it a key factor in the prognosis?
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Diagnosing the tall cell subtype of papillary thyroid carcinoma (PTC) requires refined criteria. Identifying over 10% of Cx3 cells is crucial for predicting recurrence risk and patient prognosis.
Area Of Science
- Oncology
- Pathology
- Thyroid Cancer Research
Background
- The tall cell subtype of papillary thyroid carcinoma (PTC) is associated with a poor prognosis.
- Diagnostic criteria for tall cell PTC have undergone revisions.
- Accurate identification is key to understanding tumor aggressiveness.
Purpose Of The Study
- To establish precise diagnostic criteria for the tall cell subtype of PTC.
- To correlate these criteria with tumor aggressiveness and patient prognosis.
- To refine diagnostic approaches for improved patient outcomes.
Main Methods
- Evaluated 171 cases of classic and tall cell PTC.
- Quantified tall cells using specific height-to-width ratios (C2-3 and Cx3).
- Correlated cell percentages with clinical and histopathological data, assessing interobserver agreement.
Main Results
- Only 8 cases (5%) met current WHO tall cell PTC criteria.
- A significant increase in 5-year recurrence risk was observed with >10% Cx3 cells.
- No significant recurrence rate differences were found based on C2-3 cell percentages.
- Excellent interobserver agreement (Kappa: 0.83) was achieved with reference images.
Conclusions
- Reporting Cx3 cells at ≥10% in PTC is clinically relevant due to increased 5-year recurrence rates.
- The presence of Cx3 cells is a significant indicator of PTC aggressiveness.
- Standardized reference images enhance interobserver agreement for diagnosing PTC subtypes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
